SCHEMBL14770700

SCHEMBL14770700

c1ccc(-c2ccc3c(c2)c2ccccc2n3-c2ccc3oc4ccc(-c5cncc(-n6c7ccccc7c7ccccc76)c5)cc4c3c2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 3/20 0.36
PLA2G4A P47712 3/20 0.36
CHRNB4 P30926 1/20 0.35
CHRNA3 P32297 1/20 0.35
RAC2 P15153 1/20 0.35
RAC3 P60763 1/20 0.35
CDC42 P60953 1/20 0.35
RAC1 P63000 1/20 0.35
KDM4E B2RXH2 1/20 0.35
ATM Q13315 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TSPO P30536 1/20 0.34
BTK Q06187 3/20 0.33
PIK3CD O00329 2/20 0.33
PIK3CA P42336 2/20 0.33
PIK3CB P42338 2/20 0.33
PIK3CG P48736 2/20 0.33
PIK3R1 P27986 1/20 0.33
MTOR P42345 1/20 0.33
PRKDC P78527 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14770681 1.00 PLA2G2A (0.36) PLA2G2APLA2G4ACHRNB4CHRNA3RAC2
SCHEMBL14770684 1.00 PLA2G2A (0.36) PLA2G2APLA2G4ACHRNB4CHRNA3RAC2
SCHEMBL14770687 0.98 PLA2G2A (0.36) PLA2G2APLA2G4ACHRNB4CHRNA3RAC2
SCHEMBL14770712 0.94 KDM4E (0.37) PLA2G2APLA2G4ACHRNB4CHRNA3RAC2
SCHEMBL14770711 0.94 KDM4E (0.37) PLA2G2APLA2G4ACHRNB4CHRNA3RAC2
SCHEMBL14770554 0.94 KDM4E (0.36) PLA2G2APLA2G4ACHRNB4CHRNA3KDM4E
SCHEMBL14770663 0.91 KDM4E (0.41) PLA2G2APLA2G4ARAC2RAC3CDC42
SCHEMBL14770577 0.91 KDM4E (0.43) PLA2G2APLA2G4ARAC2RAC3CDC42
SCHEMBL14770592 0.91 KDM4E (0.38) PLA2G2APLA2G4ACHRNB4CHRNA3KDM4E
SCHEMBL14770665 0.90 BTK (0.38) PLA2G2APLA2G4AKDM4EATML3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-9604972-B2 Nitrogen-containing heteroaromatic ring compound IDEMITSU KOSAN CO., LTD. (JP) 2017-03-28 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND IDEMITSU KOSAN CO., LTD. (JP) 2013-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130062597-A1 NITROGEN-CONTAINING HETEROAROMATIC RING COMPOUND TDO2, AHR, NOC2L PLA2G2A 4744/4885PLA2G4A 4639/4885CHRNB4 2572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.